Agios pharmaceuticals, inc. (AGIO)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenues:
Grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20

Total revenue

87,098

35,440

26,024

26,221

30,227

30,013

15,198

40,414

8,762

9,799

11,358

11,346

10,508

-

8,985

6,978

-

-

-

-

-

-

-

-

-

-

-

-

-

6,268

6,288

Cost and expenses:
Cost of sales

533

287

393

303

334

702

695

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

91,256

106,248

101,672

107,389

95,585

93,809

82,561

86,730

78,224

77,216

72,917

79,816

62,732

64,678

60,643

50,804

44,038

36,933

36,028

36,423

32,443

34,862

25,526

22,576

17,407

15,279

14,803

12,958

11,462

9,798

10,463

Selling, general and administrative

38,501

34,834

33,019

32,390

31,791

31,858

31,104

26,633

24,550

22,713

17,458

16,130

14,823

15,379

11,854

12,644

10,837

10,182

9,927

8,929

6,954

6,501

5,166

4,165

3,288

3,707

2,534

1,836

1,852

1,580

1,948

Total cost and expenses

130,290

141,369

135,084

140,082

127,710

126,369

114,360

113,363

102,774

99,929

90,375

95,946

77,555

80,057

72,497

63,448

54,875

47,115

45,955

45,352

39,397

41,363

30,692

26,741

20,695

18,986

17,337

14,794

13,314

11,378

12,411

Loss from operations

-43,192

-105,929

-109,060

-113,861

-97,483

-96,356

-99,162

-72,949

-94,012

-90,130

-79,017

-84,600

-67,047

-57,409

-63,512

-56,470

-23,594

-40,897

-40,475

-32,133

-5,195

-26,727

3,208

-18,330

-12,284

-12,242

-11,069

-8,526

-7,046

-5,110

-6,123

Interest income, net

2,936

3,579

2,887

3,990

4,405

4,562

4,498

4,204

3,187

1,845

1,880

1,518

881

923

678

517

396

276

218

236

238

85

48

34

36

29

13

5

8

13

22

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,256

-

-

-12,213

-11,056

-8,521

-7,038

-5,097

-6,101

Benefit from income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-448

-

-

169

121

99

190

-452

-588

Net loss

-40,256

-102,350

-106,173

-109,871

-93,078

-91,794

-94,664

-68,745

-90,825

-88,285

-77,137

-83,082

-66,166

-56,486

-62,834

-55,953

-23,198

-40,621

-40,257

-31,897

-4,957

-26,664

3,704

-18,296

-12,248

-12,382

-11,177

-8,620

-7,228

-4,645

-5,513

Cumulative preferred stock dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

567

1,798

1,797

-1,798

1,798

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-12,382

-11,744

-10,418

-9,025

-2,847

-7,311

Net loss per share – basic and diluted (in usd per share)

-0.59

-1.59

-1.81

-1.87

-1.59

-1.58

-1.63

-1.19

-1.63

-1.82

-1.59

-1.78

-1.56

-1.36

-1.63

-1.47

-0.61

-1.10

-1.07

-0.85

-0.13

-

-

-0.54

-0.39

-

-

-2.80

-2.47

-0.83

-2.18

Weighted-average number of common shares used in computing net loss per share – basic and diluted (in usd per share)

68,608

63,998

58,803

58,722

58,453

58,223

58,033

57,721

55,694

48,864

48,459

46,745

42,280

42,136

38,548

37,956

37,864

37,665

37,507

37,329

37,214

-

-

33,602

31,394

-

-

3,722

3,658

3,439

3,358

Net income (loss) per share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.11

-

-

-

-0.52

-

-

-

-

Net income (loss) per share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.10

-

-

-

-0.52

-

-

-

-

Weighted-average number of common shares used in net income (loss) per share - basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34,495

-

-

-

22,744

-

-

-

-

Weighted-average number of common shares used in net income (loss) per share - diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

36,592

-

-

-

22,744

-

-

-

-

Product revenue, net
Total revenue

22,674

19,613

17,400

13,700

9,138

9,341

4,500

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue – related party
Total revenue

60,097

6,843

5,516

8,979

17,919

18,183

8,732

26,401

7,345

8,577

10,643

11,346

10,508

-

8,985

-

31,281

6,218

5,480

13,219

34,202

14,636

33,900

8,411

8,411

6,744

6,268

6,268

6,268

-

-

Collaboration revenue – other
Total revenue

993

6,060

420

812

970

230

0

12,440

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,268

6,268

Royalty revenue – related party
Total revenue

3,334

2,973

2,666

2,703

2,200

2,224

2,001

1,573

1,417

1,222

715

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-